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Summary
Virus-specific cytotoxicT lymphocytes (CTL) recognize virus-derived peptides presented by major
histocompatibility complex (MHC) class I molecules on virus-infected cells. Such peptides have
been isolated from infected cells and were compared to synthetic peptides . We found previously
the Kd- or Db-restricted natural influenza nucleoprotein peptides to coelute on reversed phase
high performance liquid chromatography columns with certain peptidic by-products present in
synthetic peptide preparations . Here we show by extensive biochemical and immunological
comparison that the natural peptides in all respects behave as the surmised synthetic nonapeptides,
and thus, must be identical to them . The absolute amounts of these natural peptides contained
in infected cells could be determined to be between 220 and 540 copies by comparing with defined
amounts of pure synthetic nonapeptides. The comparison of the natural Kd-restricted peptide
with published synthetic peptides known to contain other Kd-restricted CTL epitopes suggested
a new MHC allele-specific T cell epitope forecast method, based on the defined length of nine
amino acid residues and on critical amino acid residues at the second and the last position .
T
he function ofMHC class I molecules is to present pep-
tides derived from cellular proteins to CD8+, MHC
class I-restricted T cells (1-7) . A considerable fraction of al-
loreactive T cells also recognizes peptides derived from cel-
lular proteins (K . Falk, unpublished data) . Such peptides can,
in principle, be derived from protein occurring in different
cellular compartments (8) . It is not known, however, where
and how the peptides are made from the protein, and how
they come into contact withMHC class I molecules . Based
on the blocking ofMHC class I-restricted antigen presenta-
tion with Brefeldin A (9, 10) and other experiments (11),
it was speculated thatMHC molecules bind peptides during
or shortly after assuming their final structure in the en-
doplasmic reticulum . It is not clear, however, whether na-
scent MHC molecules bind preformed peptides, or rather
larger molecules, or even complete protein, which then might
be trimmed to those peptides found later on bound to ma-
ture MHC molecules (12) .
To better understand these processes, the exact knowledge
of the identity ofMHC-presented peptides should be useful.
We have recentlyshown that cellular peptides can be isolated
from complete cells, or from purified MHC molecules, and
that the peptides isolated from complete cells, without prior
enrichment for MHC molecules, are still heavily dependent
onMHC expression in the respective cells (6, 12, 13 ; K . Falk,
unpublished data) .
For the minor histocompatibility and viral antigens tested,
the respective MHC-dependent peptide as seen by a given
CTL always elutes a single, sharp activity peak from reversed
phase HPLC columns, indicating that the cell makes exactly
one well-defined peptide to be seen by a given CTL . The
peptide presented by influenza-infected H-2d cells to Kd-
restricted, influenza nucleoprotein-specific CTL coelutes on
a reversed phase HPLC column together with a minor by-
product present in a synthetic peptide preparation made ac-
cording to a peptide previously reported to contain a Kd-re-
stricted influenza nucleoprotein epitope, TYQRTRALVRTG
(6, 14) . The minor byproduct was determined by ion spray
mass spectrometry to be a nonapeptide contained in the above
preparation . Similar observations were made for a Db-re-
stricted CTL epitope formerly described to be contained in
a 16-amino acid residue peptide also from influenza nucleo-
protein, IASNENMETMESSTLE (2, 6) .
To test whether such synthetic nonapeptides really are iden-
tical with the naturally processed peptides, we did extensive
biochemical and immunological comparisons. Based on the
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peptide copies present in influenza-infected cells . In addition,
we introduce a new hypothesis on the prediction ofT cell
epitopes in anMHC allele-specific way, which is based on
the knowledge of the identity of naturally processed viral
peptides.
Materials and Methods
Virus and Cells.
￿
InfluenzaA/PR/8/34 viruswas grown in the
allantoic sacs of 11-d-old embryonated chicken eggs and stored at
-70°C . Infectivitywas tested by determining the titer of hemag-
glutinating units (HAU;m 15). EL4 (H-2b), P815 (H-2d), and
PLHTR (H-2d) tumor cells were grown in RPMI 1640 sup-
plemented with 5% FCS and antibiotics. PLHTR is a subline of
P815 selected for high transfection efficiency (16) and is easier in-
fectable with influenza virus than is P815 in our hands (H. Schild,
unpublished data) . This line was erroneously called P815TR in
a previous publication (6). The CTL line HASI is specific for
influenza nucleoprotein peptideTV (for abbreviations ofpeptides,
see Tables 1 and 2) and is Kd restricted (6) . The line 28B90 was
derived by stimulating spleen cells of a C57BL/6 mouse (preim-
munized with 50 HAU of virus), with crude IASNENMET
MESSTLE peptide (1 Itg/ml) in vitro. This line has essentially the
same specificity as has the line LS9 (6), i.e., is specific forA-Mand
is Db restricted . Both CTL lines were kept by weekly restimula-
tion with irradiated (33Gy)syngeneic spleen cells and the respec-
tive peptide in a medium supplemented with 10% FCS and anti-
biotics and Con A-induced rat spleen cell supernatant as a source
of IIL2 .
Vitus Infections.
￿
EL4 cells were grown in roller bottles to a den-
sity of 1-2 x 106 cells/ml . Cells were infected by incubation with
15 x 104 HAU of virus for 109 cells in PBS (without FCS) for
12 h at 37°C ; P1.HTR cells were grown in plastic petri dishes
(14.5-cm diameter) to near confluent density (-101 cells/dish) .
Medium was removed and replaced by PBS (without FCS) con-
taining infectious virus (15 x 10^ HAU/109 cells) . Incubation at
37°C was for 12 h . Success ofinfections was controlled forby testing
a sample of infected cells for recognition by virus-specific CTL .
Extraction ofViral lkptidesfrom Infected Cells.
￿
109 virus-infected
cells were pelleted and suspended with 15 ml of 0.1% (vol/vol)
TFA. Cells were disrupted by douncing (10 strokes) followed by
ultrasonication (20 pulses of 1 s; Sonifier BIS; Branson, Heusen-
stamm, Germany) . Suspensions were then stirred for 30 min at
4°C; pH was kept at 2.0 with 1% TFA. The supernatant taken
after centrifugation (30 min ; 180,000 g; 4°C) was lyophilized,
resolved in 0.1% TFA, and subjected to a G25 Sephadex (Phar-
macia Fine Chemicals, Piscataway, NJ) column (bed volume, 50 ml;
sample volume, 3 ml; eluent, 0.1% TFA ; flow rate, 0.5 ml/min).
Material ofM r <5,000 (excluded from this column)was collected,
lyophilized, and resolved in 1 ml of0.1% TFA forHPLC separation.
Synthetic Aptides. Peptides (Tables 1 and 2) with 000H-
terminal amino acid residue L, M, or E, respectively, were synthe-
sized by solid phase techniques on a peptide synthesizer (model
430A; Applied Biosystems, Foster City, CA) usingourownFmoc
programandcommercially available Fmoc-amino acid p-benzyloxy-
benzylalcohol-resins and Fmoc-protected amino acids (Novabi-
ochem, Sandhausen, Germany) . Fmoc-amino acidswere side chain
protected as follows: Gln(Trt), Thr(tBu), Ser(tBu), Glu(tBu),
I Abbmdations used in this paper: HAU, hemagglutinating units ; VSV,
vesicular stomatitis virus .
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Asn(Trt), Arg(Mtr), Tyr(tBu) . The coupling of amino acids was
carried out in 10-fold excess within 1 h. Fmoc-amino acids (1.5
mmol)were activated in situ with 2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium tetrafluoroborate (TBTU) (481mg; 1.5 mmol),
VHOBt-DMF (1 .1 M ; 1.5 ml), and VDIEA-DMF (1M; 2.3 ml)
in 1.5 ml DMF (Merck, Darmstadt, Germany), and transferred
to resin . All other peptides were synthesized simultaneously on
a fully automated multiple peptide synthesizer (model 350 ; Zinsser,
Frankfurt/M ., Germany) . The couplingswere performedusing the
10-fold excess of Fmoc-amino acids and DCC/HOBt within 40
min. Peptides were deprotected andsimultaneously removedfrom
the resinby treatment with anhydrous TFA in the presence of3%
(vol/vol) thioanisol and p-thiocresol (Fluka, Neu-Ulm, Germany)
(3 h at the temperatures indicated below) . Nucleoprotein peptides
of the Kd-restricted series starting with Thrwere deprotected and
removed from the resin before cleaving off the NH 2-terminal
Fmoc-protectinggroup with piperidine/DMF, 1:1 (vol/vol) . Pep-
tides containing Arg(Mtr) were completely deprotected by treat-
ment with TFAplus scavenger for 1 h at 25°Cand for additional
2 h at 50°C . All other peptides were kept for only 1 h at 50°C .
The crude peptides were separated from the coupling reagents by
extraction with ether andwere lyophilized subsequently, whereby
each peptide was obtained as a colorless powder. Ion spray mass
spectrometry (Sciex, Toronto, Ontario) indicated complete deprotec-
tion of peptides (correct molecular ion peak) and the appearance
ofthe respective multiple charged species ; identity ofpeptides was
confirmed by amino acid analysis (ABI).
HPLC Separation ofNaturaland Synthetic Rptides.
￿
All separa-
tions were done on a reversed phase Superpac Pep-S column
(C2/C18, 5-pm particles, 4.0 x 250mm ; Pharmacia LKB) using
Pharmacia LKB equipment. Samples were injected in volumes of
1,000 pl in starting solution . Four different elution procedures were
used . (a) TFA/acetonitrile, standard resolution : solution A, 0.1%
TFA in H2O; solution B, 0.1% TFA in acetonitrile . 0-5 min,
100% A; 5-40 min, linear increase to 60% B; 40-45 min, 60%
B; 45-50min, linear decrease to0% B. Flow rate, 1 ml/min ; frac-
tion size, 1 ml (used in Fig. 2) . (b) Same solutions ; 0.5% increase
of B per min; fraction size, 0.5 ml (used in Fig. 1, a and b) . (c)
Phosphate buffer/acetonitrile ; solution A,0.1M sodium phosphate
(pH 3.3 in Fig. 1 c ; pH 6.5 in Fig. 1 d) ; solution B, acetonitrile .
Gradient as indicated in Fig . 1, c and d ; flow rate 1 ml/min ; frac-
tion size 0.5 ml . (d) HFB/acetonitrile; solution A, 0.1% heptaflu-
orobutyric acid (HFB) in H2O (vol/vol) ; solution B, 0.1% HFB
in acetonitrile . Gradient as indicated in Fig . 1, g and h. Flow rate,
1 ml/min ; fraction size, 0.5 ml . Elution was monitored by meas-
uring ultraviolet light absorption at 220nm in a continuous flow
detector. Individual samples were driedby vacuum centrifugation
and stored at -70°C, if not immediately used for CTL assays .
CTL Assays.
￿
EL4 (H-2b) or P815 (H-2d) target cells were la-
beled with "Craccording to standard methods . Synthetic or nat-
ural peptides were titrated into 96-well round-bottomed microtiter
plates (50 td/well). Target cells (10`/well in 100 pl of medium)
were added, followed by incubation at 37°C for 90 min . CTL sus-
pensions (50 pl) were added to give a CTL/target ratio of 2:1 to
10:1. Assay plates were incubated for6 h at 37°C . 100-P1 supema-
tant from each well was harvested and the radioactivity detected
in a gamma counter. Specific lysis was determined using the for-
mula : 100 x (cpm released byCTL - cpm released with medium
alone)/(cpm released by detergent - cpm released with medium
alone) . For assays, ot medium containing 10% FCS was used. De-
tergent used to determinemaximum release oftarget cellswas10%
Zaponin (Coulter Instruments, Hialeah, FL) . Spontaneous "Cr re-
lease of target cells was between 9 and 28%.Results
The Naturally Processed Kd-restricted Peptide from Influenza
Nucleoprotein . P1.HTR tumor cells (H-2d) were infected
with A/PR/8/34 influenza virus. Peptides were extracted
by acid elution, separated by reversed phase HPLC (TFA/
acetonitrile), and tested for recognition by Kd-restricted,
influenza nucleoprotein-specific HASI CTL as described (6;
Fig . 1 a) . We found that the natural peptide coeluted with
a synthetic byproduct of M, 1,107 contained in a prepara-
tion ofTYQRTRALVRTG (abbreviation, T-G ; M r 1,421 ;
14) . Therefore, peptides according to TYQRTRALV (TV,
M 1,107) and several other peptides contained in or over-
lapping with TG withM "1,000 (see Table 1) were syn-
thesized, and chromatographed under the same conditions
as the natural peptide . The elution behavior of these peptides
is indicated in Fig. 1 a by marks. Three of the synthetic pep-
tides eluting at similar positions as the natural peptide were
chromatographed under different conditions (phosphate
buffer/acetonitril ; Fig . 1 c) and compared to the elution be-
havior of the natural peptide under the same new conditions
(Fig. 1 e) . The TYQRTRALV peak coeluted exactly with
the natural peptide, whereas the other two synthetic pep-
tides eluted with considerably different retention times com-
pared to the natural one. Both TYQRTRALV and the nat-
ural peptide were chromatographed using yet another
parameter (heptafluorobutyric acid [HFB]/acetonitrile; Fig.
1 g) ; again, they both behaved identically. Thus, the natu-
rally processed Kd-restricted peptide from influenza nucleo-
Table 1 .
￿
Recognition of Synthetic Influenza Nucleoprotein Peptides by Kd-restricted CTL
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protein must beTYQRTRALV. Indeed, synthetic TV is rec-
ognized very well by Kd-restricted CTL HASI (down to a
concentration of 60 pg/ml [54 pM]), whereas some of the
other peptides in Table 1 are recognized with much inferior
efficiency .
The Natural Db-restricted Peptide from Influenza Nucleopro-
tein . Acid extracts from influenza-infected EL4 tumor cells
(H-2b) were separated and analyzed as for the H-2d tumor
cells, except that Db-restricted CTL 28B90 were used for de-
tection (Fig. 1 b) . The elution behavior of synthetic peptide
ASNENMETM, which had been suspected to be the one
coeluting with the natural Db-restricted peptide (6), as well
as some other peptides of similar molecular mass (Table 2),
contained in theIASNENMETMESSTLE (2) sequence is in-
dicated in Fig. 1 b by marks . Three peptides eluting similarly
as the natural peptide, peptides A-M, S-M, andA-E, as well
as the natural peptide, were chromatographed using a phos-
phate buffer/acetonitrile gradient (Fig . 1, d and f) . Only
ASNENMETM coeluted with the natural peptide ; note the
shoulder in the activity peak of the natural peptide, which
parallels the shoulder in the activity peak ofAM (Fig. 1f) .
Coelution of both peptides was also observed with the HFB/
acetonitrile gradient (Fig. 1 h) . Thus, the natural Db-restricted
influenza nucleoprotein peptide must beASNENMETM. In
line with this is the highly efficient recognition (<1 pg/ml
[1 pM]) ofAM by Db-restricted CTL as compared to the
other peptides (Table 2) . Thus, both Kd- and Db-restricted
NP, nucleoprotein .
" Single letter amino acid code .
t P815 cells (H-2d) were incubated with titrated concentrations of the respective peptides (crude) and assayed for killing with HASI CTL. Thenum-
bers indicate specific lysis at 1 kg/100 ng/10 ng/1 ng/100 pg/10 pg/1 pg/100 fg peptide per well (150 ul) .
S (.) Deletion of a residue .
NP amino acid
residues Sequence" M Abbreviation Recognition by CTV
146-154 ATYQRTRAL 1079 A-L 93/92/84/ 5/ 0/ 0/ 1/ 0
146-155 ATYQRTRALV 1178 AN 92/90/89/97/85/25/ 2/ 0
147-154 TYQRTRAL 1009 T-L 89/91/87/23/ 0/ 0/ 1/ 0
147-155 TYQRTRALV 1107 T-V 92/83/89/88/97/56/ 1/ - 2
147-158 TYQRTRALVRTG 1422 T-G 82/73/86/70/ 7/ 2/ 0/- 1
148-154 YQRTRAL 907 Y-L 78/ 8/ 3/
148-155 YQRTRALV 1006 Y-V 90/98/87/68/ 5/ 0/ 1/-2
149-154 QRTRAL 744 Q-L 1/ 2/ 2
149-155 QRTRALV 843 Q-V 5/ 31-1
150-157 RTRALVRT 972 R-T 3/ 4/ 4
TYQRTRALV .TGS 1265 78/90/83/98/76/ 7/ 1/ 0
TYQ .TRALV .TG 1109 84/30/ 0
TYQ .T .ALVRTG 1109 62/ 4/ 1
TYQRT .ALV .TG 1109 83/65/ 6N
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Identification of naturally processed viral peptides by biochemical comparison to synthetic peptides . Naturally processed influenza virus
peptides were extracted from infected P1.HTR cells and HPLC separated as described (6) . The fraction recognizedby the influenza nucleoprotein-specific,
Ka-restricted CTL line HAS[ was further separated using different HPLC parameters (left panels) . Similarly, the naturally processed influenza peptide
recognized by Db-restricted CTL 28B90 was extracted from EL4 cells, separated by HPLC, and subjected to further HPLC separation (rightpanels) .
Recognition ofindividual fractions byCTL was monitored by incubating the respective fractions with P815 target cells and measuring their lysis using
HASICTL (squares and circles), or byincubatingfractions with EL4 target cells and measuring their lysis with 28B90CTL (upright and im~erted triangles) .
(".""/ ; """ ." ) Fractions from control gradients performed without samples. This is an important control, since minor peptide contaminations
left over from previous runs might interfere with the extremely sensitiveCTL assay. These control gradients were always run before peptide separations .
(0-0 . A-A) Natural peptide, no CTL (control for toxicity of fractions) . (") Natural Kd-restricted peptide, HASI CTL . (") Natural
Db-restricted peptide, 28B90 CTL . ("---" ) Synthetic peptides YV, TV, or A-V, HASI CTL . ("-.---" ) Synthetic peptides A-E, S-M,
or A-M, 2SB90 CTL. (a and b) TFA/acetonitrile gradient . (0-*, A-A) The activity peaks of the natural peptides. The numbered
marks indicate the elution behavior of synthetic peptides . See Tables 1 and 2 for identity of these peptides. Samples of 10 ng were loaded onto the
HPLC column . Loading less peptide (10 ng) resulted in a shift of elution time of -20 s for TV, which would move the TV mark right under the
activity peak in a . (c and d) Phosphate buffer/acetonitrile gradient. The three synthetic peptides YV, TV, andAV (c) or A-E, S-M, andA-M (d) were
mixed (10 ng of each) and applied to theHPLC column . Elution profiles are indicated. Peaks were identifiedby comparison with single-peptide HPLC
profiles. (e andfi CTL recognition of natural and synthetic peptides eluted from the gradient in c and d . (g and h) HFB/acetonitrile gradient . Activity
profile of the natural peptides and TV (g) or A-M (h) is shown .
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* EL4 target cells (H-2b) were incubated with titrated amounts of the respective peptide (crude) and assayed for killing with 281390CTL. The num-
bers indicate specific lysis at 1 ug/100 ng/10 ng/1 ng/100 pg/10 pg/1 pg/100 fg peptide per well (150 141) .
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Figure 2.
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Comparative extraction of
naturally processed peptides and of
defined amounts of synthetic peptides
admixed to cells. (a-rl) Aliquots of 109
P1.HTR (H-2d) cells were left unin-
fected (a and b), were mixed with 10
ngTV synthetic peptide (b) or were in-
fected with influenza virus (c and d) .
(e-h) Aliquots of 109 EL4 cells were
left uninfected (e and J), were mixed
with 10 ngA-M synthetic peptide 0,
or were infected with influenza virus
(g and h) . Each aliquot was subjected
to acid extraction . The resulting mate-
rial was separated by reversed phase
HPLC and monitored by measuring
ultraviolet light absorption at 220nm
(
￿
). Individual fractions were
tested for recognition by HASI CTL
(Kd-restricted) on P815 target cells (")
or by 281390 CTL (Db-restricted) on
EL4 target cells (A), or were incubated
with P815 (O) or EL4 (A) target cells
without CTL to control for fraction
toxicity.
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Table 2 .
NP amino
residues
Recognition ofSynthetic Influenza Nucleoprotein
acid
Sequence
Peptides by
M r
V'-restricted CTL
Abbreviation Recognition by CTL`
364-373 QIASNENMET 1136 Q-T 88/87/ 17/ 4
364-374 QIASNENMETM 1267 Q-M 81/93/ 96/90/97/70/13/ 4
364-376 QIASNENMETMES 1484 Q-S 100/99/100/94/10/ 8/ 5
365-373 IASNENMET 1008 I-T 88/88/ 60/ 9/ 6
365-374 IASNENMETM 1139 I-M 54/70/ 80/77/83/30/ 2
365-375 IASNENMETME 1268 I-E 64/67/ 19/ 1
365-376 IASNENMETMES 1355 I-S 90/97/100/97/99/33/10/ 3
365-380 IASNENMETMESSTLE 1786 55/68/ 77/57/13/ 4/ 5
366-373 ASNENMET 895 A-T 93/91/100/50/ 10/ 3
366-374 ASNENMETM 1026 A-M 93/91/100/93/94/99/90/28
366-375 ASNENMETME 1155 A-E 64/84/ 80/ 3/ 5/ 1
366-376 ASNENMETMES 1242 A-S 83/89/100/99/97/93/19/13
367-374 SNENMETM 955 S-M 54/65/ 73/49/15/ 5/ 0
367-375 SNENMETME 1084 S-E 35/ 2/-2
367-376 SNENMETMES 1171 S-S 93/95/100/99/26/ 8/ 9/11
367-374 NENMETM 868 N-M 23/ 7/ 6/ 6
368-375 NENMETME 997 N-E -3/ 7/ 0m
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CTL epitopes ofinfluenzanucleoprotein arerecognized 100-
(TV) or 10,000-fold (AM) better than the peptides origi-
nally described to contain the respective CTL epitope (see
also below) .
Quantitation of Peptides in Infected Cells.
￿
Aliquots of 10 9
P1.HTR or EL4 cells were either mixed with 10 ng TV or
A-M, respectively, or were infected with influenzavirus . Ex-
tracted peptides from each aliquot were separated and ana-
lyzed as described earlier (6). The admixed synthetic pep-
tides as well as the natural peptides eluted at the expected
positions (Fig . 2) . Fractions containing active peptides were
retested in titrated concentrations (Fig. 3) . By comparison
of the titration curves, it was determined that the recovery
of admixed syntheticTV from P1.HTR cells was approxi-
mately quantitative (Fig . 3, b and c), and that from the first
batch of infected H-2d cells 1 ng of natural TV was eluted
(Fig. 3 d) . From the second batch, 0.4 ng of naturalTV was
eluted (Fig . 3 e) . Thus, from 109 infected H-2d cells, 1 ng
_
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Figure 3.
￿
Comparative titrations of synthetic peptides and of naturally processed peptides. (a-e) Syntheticand natural peptides were serially diluted,
incubated with P815 target cells, and tested for lysis by HASI CTL. (a and b) synthetic TG ("---") and TV
￿
The titration
in b was done simultaneously with those in the next three panels. (c-e) titrations of fractions 24 each of Fig . 2 b (admixed TV peptide subjected to
acid extraction) (c) ; of Fig . 2 c (natural peptide, first batch) (d), and of Fig. 2 d (natural peptide, second batch) (e) . The data in c-e (and also in h-k)
are plotted as to represent percent of the total amount of fraction 24 (22 in h-k) present in the assay microculture. Comparison of b and c indicates
the50% level of lysis in this experiment to correspond with a peptide concentrationof 200pg/ml (corresponding to 30 pg per microculture [volume,
150 N,1] and with 0.2% of the admixed 10 ng of TV; thus, the recovery of admixed peptide is roughly quantitative. Comparison of c with d and
e indicates that in d, 10-fold less (natural) TV than in c are detected, and in e, 25-fold less than in c is detected . Thus, the twobatches of 109 virus-
infected cells contained 1 ng, respectively, 0.4 ng of natural TV (f-k) synthetic and natural peptides were serially diluted, incubated with EL4 target
cells, and tested for lysis by 28B90 CTL. (f and g) Synthetic IASNENMETMESSTLE ("---") and A-M ("
￿
") . (h-k) Titration of
fraction 22 each of Fig . 2 (admixed A-M) (h), of Pig . 2g (natural peptide, batch 1) (1), and of Fig . 2 h (natural peptide, batch 2) (k) . Comparison
ofg and h indicates a recovery of 25% of the A-M peptide admixed to cells . Comparison of h with i and k indicates that both batches of infected
cells contained 27 fold less (natural)A-M than detected in h . Thus, the two batchesof109 virus-infected EL4 cells each contained 375 pg of natural A-M.
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TV was recovered ; this corresponds to 540 TV molecules
per cell . The 0.4 ng TV from the second batch correspond
to 220 copies per cell.
The recovery of admixed syntheticAM from EL4 cells
was25% (Fig. 3, gand h) ; assuming the same recovery rate,
both batches of infected EL4 cells contained 0.4 ng of nat-
ural A-M, or 220AM molecules per cell .
Comparison ofNatural Peptides to OtherPeptides Known to
Contain CTL Epitopes. Table 3 shows a comparison of the
naturally processed Kd-restricted influenza nucleoprotein
peptide TV with other peptides known to contain Kd-
restricted epitopes . It is evident that all have a tyrosine res-
idue ; since TV has its Tyr at position 2, we have lined up
all other peptides accordingly . Ifwe assume that Kd-restrict-
ed peptides consist of nine amino acid residues, and that Tyr
is always at position 2, the naturally processed Kd-restricted
peptides wouldbe predicted to be thoseprintedin bold letters .
On comparing theselined-up epitopes, some features are evi-
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t Circumsporozoite protein.
dent : apart from the uniform Tyr at position 2, the last posi-
tion is always occupied by an amino acid residue with a side
chain methyl group (Val, Ile, Thr, Ala, or Leu) . The third
position is frequently Glu, Leu, or Val; in the fifth position
Val, Asn, and Ser ; and in the sixth Glu and Ala are found
repeatedly. On the other hand, the fourth position is in all
cases occupied by a different amino acid, with the exception
of the homologous peptides. Similarly, positions 1, 7, and
8 are highly variable . A comparison of the natural Db-re-
stricted influenza nucleoprotein peptide with other peptides
known to contain Db-restricted epitopes was not informa-
tive, because the available database is smaller, and since a sen-
tinel residue such as Tyr for Kd-restricted peptides was not
evident . It is clear, however, that the Db-restricted peptide
does not fit into the pattern observed for Kd-restricted pep-
tides ; neither does the naturally Kb-restricted peptide of
vesicular stomatitis virus (7) .
Discussion
The naturally processed influenza nucleoprotein peptide
presented by Kd molecules to CTL was determined to be the
nonapeptide TYQRTRALV . The corresponding Db-
restricted peptide is ASNENMETM . Knowing exactly the
peptides presented by virus-infected cells, it was possible to
quantitate the number of peptide copies present in a virus-
infected cell by comparing in a CTL assay the titration curves
of eluted natural peptides with those of defined concentra-
tions of the corresponding synthetic peptides. From infected
P1.HTR tumor cells (H-2d), between 220 and 540 copies
of TYQRTRALV were extracted, and from infected EL4
tumor cells (H-2b), 220 copies of ASNENMETM .
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An unknown parameter may have biased these figures,
namely the efficiency of peptide extraction from cells. The
efficiency of peptide recovery during HPLC has been con-
trolled for. Most of the naturally processed peptides are likely
to be eluted from MHC molecules located in the cytoplasm
or on the plasma membrane. Although the condition used
for extraction (0.1% TFA) may suggest quantitative dissoci-
ation ofMHC molecules and peptides, we cannot measure
this parameter. On the other hand, we do not know how
many of the peptide copies isolatedcome from the cytoplasm
and howmany from the plasma membrane . There is no easy
way to allocate the origin of eluted peptide to either of the
two compartments. Under the assumption that half of the
peptides eluted from whole cellscome fromMHC molecules
inserted into the plasma membrane, the number of peptides
presented on the cell surface would be-100 for infected EL4
cells, and -100-300 for infected P1.HTR cells . These
numbers are consistent with the minimal number of peptide/
MHC complexes for stimulatingMHC class II-restricted T
cells (17, 18) . If the tumor cells used in our study express
300,000 Kd or Db molecules per cell, respectively, these
should be able to present 1,000-3,000 different peptides simul-
taneously in sufficient densities to allow T cell recognition .
In normal cells, all of these are self peptides ; indeed, normal
cells can be recognized by quite a lot of different peptide-
specific CTL (12, 13 ; K . Falk, unpublished data) . The body
cells of individual human beings typically express four different
MHC class I molecules capable ofpresenting peptides (HLAA
and -B in two allelic forms each) ; normal outbred mice have
four or six such molecules. This implicates that one cell (with
highMHC expression) is able to present 12,000 different pep-
Table 3. Comparison of Natural K4-restricted Peptides to Other Peptides Known to Contain K4-restricted CTL Epitopes
Amino acid
Organism Protein residues Sequence" Restriction Reference
Influenza A/PR/8/34 Nucleoprotein 147-155 TYQRTRALV Kd 6
Influenza A/JAP/305 Hemagglutinin 523-545 VYQILAIYA TVAGSLSLAIMMAG Kd 23
Influenza A/JAP/305 Hemagglutinin 523-545 VYQILA IYATVAGSL S LA IMMAG Kd 23
Influenza A/PR/8 Hemagglutinin 518-528 IYSTVASSL V L Kd 24
Influenza A/JAP/305 Hemagglutinin 202-221 RT LYQNVGTYV SVGTSTLNK Kd 23
Influenza A/JAP/305 Hemagglutinin 202-221 RZLYQNVGTYVSVGTST LNK Kd 23
Human HLA-A24 170-182 RYLENGKET LQRA Kd 25
Human HLA-Cw3 171-186 RYLKNGKET LQRA Kd 25
Mouse tumor (P815) Unknown LYQAVTTTL E E Kd 26
Plasmodium berghei CS proteint 249-260 NDDSYIPSAEKI Kd 27
Plasmodium yoelii CS protein$ 276-280 NED SYVPSAEQI LEFVKQI Kd 27
Plasmodium yoelii CS proteint 281-296 SYVPSAEQI LEFVKQI Kd 28
Influenza A/PR/8/34 Nucleoprotein 366-374 ASNENMETM Db 6
VSV Nucleoprotein 52- 59 RGYVYQ- GL Kb 7tides simultaneously. This appears a high number at first
glance; the number, however, is too low to guarantee a full
covering ofany mutation occurring in the genes for the 10,000
proteins or so expressed in a cell, since each average sized
protein could give rise to 100 ormore different nonapeptides .
The number of simultaneously presented peptides is prob-
ably even lower than estimated above, since the self peptide
mixtures eluted from MHC class I molecules contain 7-10
dominant peptides likely to occupy much >300MHC mol-
ecules per cell (7 ; O. Rotzschke, unpublished data) . Thus,
ifCTL are involved in the surveillance of normal cells against
somatic mutation, as has been speculated, this surveillance
has to be incomplete, even if our calculation should grossly
underestimate the actual number of different peptides simul-
taneously presented by a cell .
In the case of cells infected with virus or larger parasites,
however, the situation is not so hopeless for a successful sur-
veillance by CTL . Each of the parasites needs at least several
of its proteins expressed intracellularly; if, on average, the
cell can afford to present one peptide per protein to CTL,
the chance for hitting a peptide derived from a foreign pro-
tein expressed in addition to the 10,000 or so self proteins
is quite high in infected cells . It should be emphasized in this
context that a cell has no possibility to distinguish between
self or nonself origin of its proteins .
The data base of naturally processed peptides presented by
MHC class I molecules consists of only three peptides up
to now ; in addition to the Kd- and Db-restricted influenza
epitopes dealt with here, a Kb-restricted vesicular stomatitis
virus (VSV) epitope has been reported to be an octapeptide
(7) . This limited information does not allow yet to gener-
alize thatMHC class I-restricted T cell epitopes are always
nona- or octapeptides, although this is not unlikely. Before
a larger data base on naturally processed epitopes is available,
however, the comparison of natural peptides to other pep-
tides known to contain CTL epitopes can be informative,
as discussed below.
It has been observed that a Tyr residue is common to pep-
tides containing Kd-restricted epitopes. One could speculate
then that Tyr residues in Kd-restricted epitopes might always
be at position two, as is the case with the natural Kd-
restricted epitope TYQRTRALV. Under this assumption,
comparison of the latter epitope with other peptides con-
taining Kd-restricted epitopes suggests a consensus sequence
for Kd-restricted T cell epitopes (Table 3) . Peptides presented
by Kd molecules generally might be nonapeptides, might
have a Tyr residue at position 2, and an amino acid residue
containing a side chain methyl group (Val, Ile, Thr, Ala, or
Leu) at position 9 (Table 4) . The other residues appear to
be more variable, although there seem to be preferential oc-
cupancies at positions 3, 5, or 6 . This hypothetical consensus
motif is consistent with replacement studies carried out by
Maryanski et al . (19), who showed that in derivatives of the
Kd-restricted peptide RYLENGKETLQRA, all amino acids
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Indicates variable occupancy . Size of letters corresponds to the impor-
tance of the respective residue .
between Tyr and Thr can be replaced by Pro residues without
abrogation of binding capacity to Kd . In addition, replace-
ment of Tyr at both the above-mentioned peptide and the
peptide TYQRTRALVTG for Ala severely reduced binding
capacity to Kd. The consensus motif hypothesized here has
now essentially been confirmed by sequencing the mixture
of self peptides eluted from Kd molecules (20) . It should be
emphasized here, however, that binding toMHC is only one
requirement a peptide has to fulfill to be naturally presented
byMHC ; other constraints may include intracellular trans-
port mechanisms (11) of proteins/peptides, and the intracel-
lular proteolysis of protein yielding the final peptide. The
comparison in Table 3 leading to the consensus motifin Table
4 is based only on epitopes actually presented by infected or
transfected cells ; peptides shown to just bind to Kd were not
considered in both tables.
The natural Db-restricted influenza peptide ASNEN-
METM does not fit into the Kd-restricted consensus se-
quence; neither does the natural Kb-restricted VSV sequence
RGYVYQGL . Thus, it may emerge that each MHC allelic
product has its own peptide motif that it likes to present to
T cells . This notion has been confirmed by recent work from
this laboratory (20) . Similar speculations have been formu-
lated earlier (19-22) ; the notion, however, is significantly
strengthenedby the identification of naturally presented pep-
tides. It may be useful, therefore, to refine anyT cell epitope
forecasts to allele-specific ones, like the one offered in Table
4 for Kd-restricted epitopes .
The presentation of nonrandom, relatively rare allele-specific
peptide motifs by MHC molecules could be a way for cells
to ensure that not too many peptides from a single abundant
protein are presented on the expense of peptides from less
abundant proteins . The relatively rare occurrence of allele-
specific peptide motifs (for example, a Tyr residue followed
by either ofVal, Ile, Thr, Ala, or Leu exactly seven positions
later for a Kd-restricted peptide ; the chance for this is 1 in
80 random nonapeptides) also implies that it is of advantage
for an individual to express several differentMHC molecules
to increase the chance that one of the peptide motifs covered
is contained in a given foreign protein, that is, to be hetero-
zygous for MHC alleles .
Table 4 . Consensus forK4-restricted Epitopes
Positions 1 2 3 4 5 6 7 8 9
V
I
Residues Y V A T
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